Viewing Study NCT00729157


Ignite Creation Date: 2025-12-24 @ 6:44 PM
Ignite Modification Date: 2026-01-21 @ 3:02 PM
Study NCT ID: NCT00729157
Status: COMPLETED
Last Update Posted: 2017-03-15
First Post: 2008-08-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Thyroid Gland Carcinoma View
None Stage III Thyroid Gland Follicular Carcinoma View
None Stage III Thyroid Gland Papillary Carcinoma View
None Stage IV Thyroid Gland Follicular Carcinoma View
None Stage IV Thyroid Gland Papillary Carcinoma View
Keywords: